Clinical Trial Update: A Dose Ranging Study of Modafinil for Methamphetamine Dependence [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study of Modafinil for methamphetamine dependence; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amphetamine Dependence
• Methamphetamine Dependence
• Substance Dependence

Drugs mentioned

• Provigil (Modafinil)

Snippet

Sponsor: California Pacific Medical Center Research Institute | Conditions: Substance Dependence, Amphetamine Dependence | Phase 2 | Status: UNKNOWN